12–17 Jul 2026
University of Graz
Europe/Vienna timezone

Modelling Ocular Disease: From Mechanisms to Treatment

Not scheduled
20m
University of Graz

University of Graz

Minisymposium Cutting Edge Research Areas Modelling Ocular Disease: From Mechanisms to Treatment

Speakers

Ben Ashby (University of Bath) Moussa Zouache (University of Utah) Neda Khodabakhsh Joniani (The University of Sydney) Patricia Lamirande (Université de Montréal)

Description

Vision loss and ocular disease constitute major global health challenges. In recent years, mathematical ophthalmology has experienced substantial growth and increasing acceptance within the clinical and biomedical communities, driven by advances in ocular imaging, experimental measurement, and the availability of high-quality clinical and preclinical data.

This mini-symposium will highlight recent mathematical advances in understanding ocular disease mechanisms and progression, as well as developments in modelling approaches that inform and optimise treatment strategies. Ocular disease involves inherently multi-physics processes, and consequently, its modelling spans a broad range of mathematical methodologies. Contributions will include, but will not be limited to, continuum and discrete frameworks, multiscale and multi-physics approaches, and data-informed models. These methods will be applied across diverse problem areas in ophthalmology, including ocular biomechanics, fluid dynamics, electrophysiology, disease progression, and drug delivery within the eye.

By bringing together researchers working across a range of ocular diseases, the mini-symposium aims to foster focused discussion and cross-fertilisation of ideas, provide a forum for the presentation of recent research to the mathematical biology community, and highlight emerging directions in the field. The session will also support the development of new collaborations.

Authors

Jessica Crawshaw (Queensland university of Technology) Neda Khodabakhsh Joniani (The University of Sydney)

Presentation materials

There are no materials yet.